Here are four quick facts:
1. The company’s total short interest reached 337,000 shares in February.
2. During the last trading session, Amedica’s shares increased 10.68 percent.
3. Since July 17, 2015, the shares have declined nearly 73 percent.
4. Amedica’s shares have underperformed the S&P 500 by 64.34 percent.
More articles on devices:
26 spine devices receive FDA 510(k) clearance in January
Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew: Who had the best 2015? 32 things to know
Cervical artificial disc replacement & lateral spine surgery: 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
